Pontin was also identified in screens of biomarker/autoantigen panels for ductal carcinoma in situ (DCIS) as well as node negative early stage breast cancers (Table 1) (Lacombe et al., 2013, 2014). Here, RUVBL1 is linked to ductal breast carcinoma in situ.